As India prepares to mark its 80th Independence Day on August 15, its pharmaceutical industry has quietly delivered a milestone, since 1947, that fits the occasion better than most.
On May 30, 2026, the US Food and Drug Administration (USFDA) approved Zaynich, an injectable antibiotic for drug-resistant urinary tract infections developed by Mumbai-based Wockhardt.